Syncope: From Etiopathogenesis to New Therapeutic Options

Syncope is a common condition related to transient loss of consciousness due to global cerebral hypoperfusion and caused by a variety of aetiologies. Although it is self-limited, and usually benign, syncope can be the harbinger of life-threatening heart rhythm problems due to cardiac conditions.

Tolga Aksu, MD, FESC, FEHRA

Dr, Aksu is a Professor of Cardiology. Currently a member of the Department of Cardiology and Director of Clinical Electrophysiology at the Yeditepe University Hospital in Turkey. Dr. Aksu is clinically interested in invasive electrophysiology, device implantation and catheter ablation therapies. Special interest areas include Atrial fibrillation and cardioneuroablation, and has been a pioneer and advocate in this field. Dr. Aksu has published more than 130 international scientific publications. He is an Associate Editor of Journal of Electrocardiology and SoMe Editor of JICE. He is also a member of the Editorial Board of World Journal of Cardiology, Medicine Journal, Journal of Atrial Fibrillation, and Journal of Cardiac Arrhythmias.

Carlos A. Morillo, MD, FRCPC, FACC, FHRS, FESC

Prof Carlos A. Morillo is a cardiac electrophysiologist, and served as the Chief Division of Cardiology (2015-2022) at the Libin Cardiovascular Institute, University of Calgary, Calgary, Alberta, Canada, and currently on an academic sabbatical leave at the Molecular and Novel Arrhythmia Mechanisms group at the Centro Nacional de Investigaciones Cardiovaculares (CNIC) in Madrid, Spain. He has been involved in syncope research since 1986, and has extensively investigated the mechanisms of neurally mediated syncope and participated and led several landmark clinical trials related with the diagnosis and management of vasovagal syncope including the VPS, POST and SPAIN trials. Prof Morillo has published over 350 peered reviewed articles and has also participated in several syncope guidelines from the ESC, ACC, AHA, HRS and Canadian Society of Cardiology. Prof Morillo’s key research areas are related to the development of clinical trials in the area syncope, cardiac arrhythmias, AF ablation, screening and detection of AF in varied populations, and treatment of Chagas Disease.